SEC Form 3 · accession 0001697684-17-000001
CHINA GEWANG BIOTECHNOLOGY, INC. · CGWB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Han Xu
10% Owner
Period of report
Jan 18, 2016
Accepted (ET)
Feb 9, 2017 · 1:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001489902
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 7,100,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Pursuant to Note to Paragraph (a) under Rule 16a-1, 19,000,000 common shares as to which the Reporting Person holds voting control under contract but with respect to which the Reporting Person has no direct or indirect pecuniary interest are not identified in this Submission as beneficially owned by the Reporting Person.